p62/SQSTM1-Dependent Autophagy of Lewy Body-Like α-Synuclein Inclusions

α-Synuclein is the main component of Lewy bodies, the intraneuronal inclusion bodies characteristic of Parkinson’s disease. Although α-synuclein accumulation is caused by inhibition of proteasome and autophagy-lysosome, the degradation of α-synuclein inclusions is still unknown. Formation of Lewy body-like inclusions can be replicated in cultured cells by introducing α-synuclein fibrils generated in vitro. We used this cell culture model to investigate the autophagy of α-synuclein inclusions and impaired mitochondria. The intracellular α-synuclein inclusions immediately underwent phosphorylation and ubiquitination. Simultaneously they were encircled by an adaptor protein p62/SQSTM1 and directed to the autophagy-lysosome pathway in HEK293 cell line. Most phospho-α-synuclein-positive inclusions were degraded in 24 h, however, lysosomal dysfunction with bafilomycin A1 significantly affected their clearance. Moreover, inhibition of autophagy by Atg-5 siRNA treatment reduced the incorporation of α-synuclein inclusions into LC3-positive autophagosomes. Knockdown experiments demonstrated the requirement of p62 for α-synuclein autophagy. These results demonstrate that α-synuclein inclusions are preferred targets for p62-dependent autophagy. Next, we investigated the autophagic clearance of impaired mitochondria in α-synuclein inclusion-containing cells. Impaired mitochondria were almost completely eliminated after mitochondrial uncoupling even in the presence of α-synuclein inclusions, suggesting that mitochondrial clearance is not prevented by α-synuclein inclusions in HEK293 cells.

[1]  B. Hyman,et al.  Distinct Roles In Vivo for the Ubiquitin–Proteasome System and the Autophagy–Lysosomal Pathway in the Degradation of α-Synuclein , 2011, The Journal of Neuroscience.

[2]  A. Kakita,et al.  Alteration of autophagosomal proteins (LC3, GABARAP and GATE-16) in Lewy body disease , 2011, Neurobiology of Disease.

[3]  Masaki Tanaka,et al.  p62/SQSTM1 in autophagic clearance of a non-ubiquitylated substrate , 2011, Journal of Cell Science.

[4]  C. Olanow,et al.  Parkinson's disease, proteins, and prions: Milestones , 2011, Movement disorders : official journal of the Movement Disorder Society.

[5]  V. Choubey,et al.  Mutant A53T α-Synuclein Induces Neuronal Death by Increasing Mitochondrial Autophagy* , 2011, The Journal of Biological Chemistry.

[6]  R. Takahashi,et al.  Ammonium chloride and tunicamycin are novel toxins for dopaminergic neurons and induce Parkinson’s disease‐like phenotypes in medaka fish , 2010, Journal of neurochemistry.

[7]  T. Iwatsubo,et al.  Seeded aggregation and toxicity of {alpha}-synuclein and tau: cellular models of neurodegenerative diseases. , 2010, The Journal of biological chemistry.

[8]  Steve D. M. Brown,et al.  α-Synuclein impairs macroautophagy: implications for Parkinson’s disease , 2010, The Journal of cell biology.

[9]  Masaki Tanaka,et al.  Extracellular neurosin degrades α-synuclein in cultured cells , 2010, Neuroscience Research.

[10]  R. Xavier,et al.  Genome-wide analysis reveals mechanisms modulating autophagy in normal brain aging and in Alzheimer's disease , 2010, Proceedings of the National Academy of Sciences.

[11]  T. Yao The role of ubiquitin in autophagy-dependent protein aggregate processing. , 2010, Genes & cancer.

[12]  Helene Knævelsrud,et al.  Fighting disease by selective autophagy of aggregate‐prone proteins , 2010, FEBS letters.

[13]  N. Hattori,et al.  PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy , 2010, The Journal of cell biology.

[14]  M. Komatsu,et al.  Physiological significance of selective degradation of p62 by autophagy , 2010, FEBS letters.

[15]  E. Waxman,et al.  A novel, high‐efficiency cellular model of fibrillar α‐synuclein inclusions and the examination of mutations that inhibit amyloid formation , 2010, Journal of neurochemistry.

[16]  D. Galasko,et al.  Selective Molecular Alterations in the Autophagy Pathway in Patients with Lewy Body Disease and in Models of α-Synucleinopathy , 2010, PloS one.

[17]  Ted M. Dawson,et al.  PINK1-dependent recruitment of Parkin to mitochondria in mitophagy , 2009, Proceedings of the National Academy of Sciences.

[18]  J. Trojanowski,et al.  Exogenous α-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells , 2009, Proceedings of the National Academy of Sciences.

[19]  L. Bubacco,et al.  Structural insights on physiological functions and pathological effects of ±‐synuclein , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  Jennifer Lippincott-Schwartz,et al.  Ubiquitin signals autophagic degradation of cytosolic proteins and peroxisomes , 2008, Proceedings of the National Academy of Sciences.

[21]  R. Youle,et al.  Parkin is recruited selectively to impaired mitochondria and promotes their autophagy , 2008, The Journal of cell biology.

[22]  Z. Elazar,et al.  Autophagy-independent incorporation of GFP-LC3 into protein aggregates is dependent on its interaction with p62/SQSTM1 , 2008, Autophagy.

[23]  Kostas Vekrellis,et al.  Wild Type α-Synuclein Is Degraded by Chaperone-mediated Autophagy and Macroautophagy in Neuronal Cells* , 2008, Journal of Biological Chemistry.

[24]  Tianhong Pan,et al.  The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease. , 2008, Brain : a journal of neurology.

[25]  Antonia P. Sagona,et al.  Ref(2)P, the Drosophila melanogaster homologue of mammalian p62, is required for the formation of protein aggregates in adult brain , 2008, The Journal of cell biology.

[26]  Masaki Tanaka,et al.  cAMP‐dependent regulation of spinesin/TMPRSS5 gene expression in astrocytes , 2008, Journal of neuroscience research.

[27]  C. Shults Lewy bodies. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Peter T. Lansbury,et al.  Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy , 2004, Science.

[29]  M. Vila,et al.  Genetic clues to the pathogenesis of Parkinson's disease , 2004, Nature Medicine.

[30]  He-Jin Lee,et al.  Clearance of α-Synuclein Oligomeric Intermediates via the Lysosomal Degradation Pathway , 2004, The Journal of Neuroscience.

[31]  A. Goldberg,et al.  Protein degradation and protection against misfolded or damaged proteins , 2003, Nature.

[32]  Jeremy N. Skepper,et al.  α-Synuclein Is Degraded by Both Autophagy and the Proteasome* , 2003, Journal of Biological Chemistry.

[33]  E. Kuusisto,et al.  Ubiquitin-binding protein p62 is present in neuronal and glial inclusions in human tauopathies and synucleinopathies , 2001, Neuroreport.

[34]  J. Trojanowski,et al.  Synucleinopathies: clinical and pathological implications. , 2001, Archives of neurology.

[35]  T. Chase,et al.  Degradation of α-Synuclein by Proteasome* , 1999, The Journal of Biological Chemistry.

[36]  Peter T. Lansbury,et al.  Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease , 1998, Nature Medicine.

[37]  R. Youle,et al.  Mechanisms of mitophagy , 2010, Nature Reviews Molecular Cell Biology.